ESC 365 - Interleukin-6 and cardiovascular prognosis in apparently healthy individuals

ESC2025 Premium Access

Interleukin-6 and cardiovascular prognosis in apparently healthy individuals

Session: Late-Breaking Clinical Science: inflammation and immune biomarkers in cardiovascular risk prediction

Topic: Cardiovascular Risk Assessment

Speaker: Doctor B. Kurt (Aachen, DE)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Berkan Kurt

RWTH University Hospital Aachen, Aachen (Germany)

1 presentation

0 follower

5 more presentations in this session

Coronary and systemic inflammation: the ORFAN study

Speaker: Doctor K. Chan (Oxford, GB)

hsCRP and Long-term CV Outcomes among SMuRF-Less Women

Speaker: Doctor P. Ridker (Boston, US)

C-reactive protein and cardiovascular risk in the general population

Speaker: Professor F. Kahles (Aachen, DE)

THYM-AF Study: T-Cell Subsets and Atrial Fibrillation

LoDoCo2: Effect of Colchicine on Clonal Hematopoiesis and Inflammatory Biomarkers

Speaker: Mr N. Mohammadnia (Nijmegen, NL)

Access the full session

Late-Breaking Clinical Science: inflammation and immune biomarkers in cardiovascular risk prediction

Speakers: Doctor B. Kurt, Doctor K. Chan, Doctor P. Ridker, Professor F. Kahles, Mr N. Mohammadnia

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources